Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

345

HTML

2265

Figures (1-1)

231

Tables (1-4)

229

Sum=3070

Nov 26, 2011 (publication date) through Jan 23, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Cardiol. Nov 26, 2011; 3(11): 367-373
Published online Nov 26, 2011. doi: 10.4330/wjc.v3.i11.367

Table 4 Long-term clinical outcomes after discharge (¹n = 178)

	n (%)
Major adverse cardiac events	31 (22.9)
Death	21 (15.5)
Cardiac death	17 (12.6)
Non-cardiac death	4 (2.9)
Myocardial infarction	8 (5.9)
Target lesion revascularization	15 (11.1)
Major hemorrhagic event	10 (7.4)
Stroke
Hemorrhagic stroke	3 (2.2)
Ischemic stroke	2 (1.5)
Definite/probable stent thrombosis	6 (4.4)
Possible stent thrombosis	8 (5.9)

¹Patients who died during index admission were excluded from this analysis.

Citation: Brugaletta S, Martin-Yuste V, Ferreira-González I, Cola C, Alvarez-Contreras L, Antonio MD, Garcia-Moll X, García-Picart J, Martí V, Balcells-Iranzo J, Sabaté M. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(11): 367-373
URL: https://www.wjgnet.com/1949-8462/full/v3/i11/367.htm
DOI: https://dx.doi.org/10.4330/wjc.v3.i11.367